StockWatch
·
Biotechnology: Pharmaceutical Preparations
DealsJun 12, 2026, 06:07 AM

NeOnc Technologies to Raise $5M via Convertible Preferred Stock Sale

AI Summary

NeOnc Technologies Holdings, Inc. entered into a Securities Purchase Agreement to issue and sell up to $5 million of Series A Convertible Preferred Stock to accredited investors. The stock is priced at $833.34 per share. The issuance is exempt from registration under Section 4(a)(2) of the Securities Act. The company also amended its Certificate of Incorporation to authorize the Series A Preferred Stock, which has specific liquidation preferences and redemption/conversion terms. The company must file a registration statement for the resale of common stock issuable upon conversion.

Key Highlights

  • NeOnc Technologies Holdings to issue up to $5 million in Series A Convertible Preferred Stock to accredited investors.
  • Series A Preferred Stock priced at $833.34 per share, with up to 6,000 shares authorized.
  • The issuance qualifies for exemption under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
  • Company agreed to file a registration statement for resale of common stock issuable upon conversion.
  • Series A Preferred Stock ranks senior to common stock in liquidation preference.
  • Company has redemption rights for Series A Preferred Stock within four months, with potential extensions.
  • Conversion to common stock occurs if redemption is not elected, with conversion price at 80% of the lowest 5-day closing price, subject to limitations.